(PharmaNewsWire.Com, February 26, 2021 ) The report "Resuscitation Devices Market by Product (Defibrillator, Endotracheal & Tracheostomy Tube, Masks, Airways, Laryngoscopes, Resuscitators, Ventilators), Patient Type (Neonatal, Adult), End User (Hospital, Ambulance, ICU), Volume - Global Forecast to 2025" The global Resuscitation Devices Market is projected to reach USD 8.7 billion by 2025 from USD 6.9 billion in 2020, at a CAGR of 4.7% during the forecast period.
Browse 145 market data Tables and 36 Figures spread through 187 Pages and in-depth TOC on "Resuscitation Devices Market - Global Forecast to 2025"
The growth in the global resuscitation devices market is driven by the rising prevalence of target diseases, increasing demand for emergency care, growing focus on providing public-access defibrillators, high incidence of preterm births, and training & awareness programs on defibrillators. Also, emerging markets and the development of wearable defibrillators are expected to offer growth opportunities for players operating in this market.
Airway management devices segment accounted for the largest share of the resuscitation devices market in 2019
On the basis of product, the resuscitation devices market is segmented into external defibrillators, airway management devices, convective warming blankets, and other resuscitation devices. The airway management devices segment accounted for the largest share of this market in 2019, majorly due to the high prevalence of chronic respiratory diseases, increasing demand for emergency care, and the high incidence of preterm births.
Hospitals, ASCs, and cardiac centers segment accounted for the largest share of the resuscitation devices market, by end user, in 2019
Based on end user, the resuscitation devices market is segmented into hospitals, ambulatory surgical centers (ASCs), and cardiac centers; pre-hospital care centers; and other end users. Hospitals, ASCs, and cardiac centers were the largest end users of resuscitation devices in 2019. The launch of training programs to efficiently undertake and operate lifesaving defibrillation procedures, increasing number of donations with regard to the purchase/implementation of defibrillators, and growing number of trauma cases and road accidents across the globe are few of the major factors driving the growth of this end-user segment.
North America accounted for the largest share of the resuscitation devices market in 2019
In 2019, North America accounted for the largest share of the resuscitation devices market. The rising geriatric population, increasing incidence of cardiac and respiratory diseases, and continuous technological advancements and product innovations are the major factors driving the growth of the resuscitation devices market in North America. Also, increasing efforts by governments to provide the necessary care to cardiac arrest victims at public places through public-access defibrillation programs have increased the demand for emergency care in the region.
Prominent players in the resuscitation devices market include Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), ZOLL Medical Corporation (US), ResMed, Inc. (US), Physio-Control (acquired by Stryker Corporation, US), Drägerwerk AG & CO. KGaA (Germany), Smiths Medical (US), Ambu (Denmark), Cardinal Health (US), Mindray Medical (China), Nihon Kohden (Japan), Teleflex (US), Salter Labs (US), GE Healthcare (US), Roper Technologies (US), Vyaire Medical (US), Intersurgical (UK), 3M (US), Flexicare (UK), and KARL STORZ (Germany).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
